Amphetamine Drug Market Trends

Growth Drivers

• The rising number of ADHD patients globally
  According to the survey done by the Centers for Disease Control and Prevention (CDC) in 2016, 0.388 million children aged 2–5 years, 4 million children aged 6–11 years, and 3 million children aged 12–17 years were diagnosed with ADHD in the United States.
  
  Rising incidences of ADHD across the globe can be attributed to the low threshold of diagnostic criteria. The number of ADHD patients is rising at an alarming rate, as there is no established treatment for this disorder except for long medication procedures. Pharmacological treatments through CNS stimulants such as amphetamine are the most appropriate way to treat ADHD patients. Such factors are expected to fuel revenue growth of the global amphetamine drug market.
• Continuous Innovation by ADHD drug manufacturers
  Market key players are continuously focusing on both, ADHD children and adults. For children, drugs are being manufactured with innovative ideas such as introducing fruit-flavors pills for easy consumption, while for adults, the focus is on reducing their daily dose by providing those doses with long-lasting effects. The packaging is another area of innovation, where blister packs are introduced instead of bottles to facilitate quick and convenient use. Manufacturers are also focusing on offering products, comparatively at lower costs. This factor is anticipated to increase the demand for amphetamine drugs in the coming years.

Challenges

• Adverse effects associated with amphetamine drugs
  Amphetamine generally involves larger and longer doses, which can develop some greater risk to the quality of a patient’s life. There are physical and psychological effects of this drug. The physical effects consist of cardiovascular side effects, gastrointestinal side effects, and other physical side effects such as blurred vision, nose bleeding, dry mouth, and others. Whereas, psychological side effects contain apprehension, mood swings, insomnia, wakefulness, and others. A large number of contraindications and side-effects associated with amphetamine drugs are limiting prescriptions based on the therapeutic condition of patients. Despite all the advantages, contraindications and side-effects associated with amphetamine drugs are hampering the life of patients, which is estimated to restrict the growth of the amphetamine drugs market over the forecast period.